Myeloproliferative Disorders
📧 Sign up to get email alerts when something new happens for Myeloproliferative Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CPI-0610 with and without ruxolitinib in hematologic and myeloproliferative malignancies; study complete…
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders [Phase 2]
Phase 2 clinical trial update on donor peripheral stem cell transplantation for patients with advanced hematologic cancers and related disor…
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies [Phase 2]
Phase 2 clinical trial update on shorter course tacrolimus after non-myeloablative conditioning with related donor PBSCT and high-dose postt…
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow [Phase 2]
Phase 2 trial update on specialized blood cell transplants for cancers of the blood and bone marrow; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating combination chemotherapy with donor stem cell transplant for aplastic anemia and hematologic cancers; compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor [Phase 2, Phase 3]
Clinical trial update on ATIR donor lymphocyte preparation for haploidentical stem cell transplantation; study terminated with posted result…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Bone Marrow Transplant in Treating Patients With Hematologic Cancers [Phase 2]
Phase 2 clinical trial update on bone marrow transplant for hematologic cancers (completed).
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant [Phase 2]
Phase 2 trial update on non-myeloablative conditioning for unrelated donor umbilical cord blood transplant completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter [Phase 3]
Phase 3 trial studying dalteparin to prevent complications in cancer patients receiving chemotherapy via a catheter completed.
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder [Phase 2]
Phase 2 trial evaluating arsenic trioxide, ascorbic acid, dexamethasone, and thalidomide in chronic myeloproliferative disorders, leukemia, …
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial [Phase 3]
Phase 3 clinical trial update focusing on personalized or basic information to aid decision-making for participating in a trial.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Treatment for Chronic Pain in Patients With Advanced Cancer [Phase 3]
Phase 3 clinical trial update for a treatment addressing chronic pain in patients with advanced cancer; status indicates completed.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders [Phase 2]
Phase 2 trial update of an allogeneic hematopoietic cell transplant in hematologic cancers/disorders; status completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT [Phase 2]
Phase 2 clinical trial evaluating irradiation-based myeloablative conditioning followed by regulatory T cell and conventional T cell immunot…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders [Phase 2]
Phase 2 clinical trial evaluating post-infusion allogeneic cytokine-induced killer (CIK) cells as consolidative therapy in myelodysplastic s…
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated prophylaxis for graft-versus-host disease using post-transplant cyclophosphamide and ruxolitinib in pat…
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation with sirolimus and treated immune cells, for blood and lymph cancers, terminated wi…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Experimental Bone Marrow Transplant Protocol [Phase 2]
Phase 2 clinical trial update for an experimental bone marrow transplant protocol that investigated treatment in blood cancer conditions; st…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer [Phase 2]
Phase 2 trial update on a combination chemotherapy, bone marrow transplant, and post-transplant cyclophosphamide regimen for hematologic can…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer [NA]
This clinical trial update reports completion of a study evaluating chemotherapy and total-body irradiation followed by donor umbilical cord…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Preservation of Ovarian Function After Hematopoietic Cell Transplant [Phase 2]
Phase 2 trial investigating preservation of ovarian function after hematopoietic cell transplantation in patients with hematologic cancers; …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating busulfan, fludarabine, and total-body irradiation as conditioning for donor stem cell transplantation …
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases [Phase 2]
Phase 2 study evaluating T-cell depletion and donor hematopoietic stem cell transplantation with T-cell infusions in patients with various h…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases [NA]
This ClinicalTrials.gov update reports on a completed study evaluating whether music can reduce anxiety and pain in adults undergoing bone m…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 1]
Phase 1 study evaluating alemtuzumab with combination chemotherapy followed by donor lymphocyte infusion in patients undergoing donor stem c…